Random tests cannot close a follow-up plan

A carrier may have several negative drug-test results for a driver and still lack the tests needed to complete that driver’s follow-up plan. The reason for each test matters. DOT’s existing rules prohibit substituting random tests for follow-up testing directed by a substance abuse professional, or SAP. This resource explains that distinction for trucking employers administering a required plan after a drug-or-alcohol program violation. It reports no new rule or enforcement case. The practical question is whether the carrier can account for the prescribed follow-up work, rather than whether a driver has been tested frequently.

The SAP establishes the written plan after determining that the employee has complied with prescribed education or treatment. Under 49 CFR 40.307, the SAP determines the testing frequency, number and whether drugs, alcohol or both are covered; the employer chooses actual dates. The minimum is six unannounced follow-up tests during the first 12 months of safety-sensitive duty, and the SAP can require more testing, including during the following 48 months of such duty. Six is therefore a floor, not a universal completion target. Time away from safety-sensitive work does not simply consume the plan: the rule’s examples preserve remaining requirements through a job change or layoff.

Keep two different testing streams distinct. Section 40.309 says other tests, including random-program tests, cannot substitute for the follow-up requirement. A cancelled follow-up test also cannot be counted as completed and must be recollected. Consider a hypothetical carrier whose records show four completed follow-up tests and two negative random tests. Our editorial reading is that the random results add nothing to its follow-up tally; the carrier must assess the four completed tests against the actual plan. A spreadsheet total labelled only “tests this year” hides the information needed to answer that question. Record the test reason and resolved outcome so the responsible administrator can reconcile like with like.

Return-to-duty is a separate stage as well. Section 40.305 requires the applicable return-to-duty test after the SAP’s successful-compliance determination, with a negative drug result and/or an alcohol concentration below 0.02 before safety-sensitive work resumes. Meeting those conditions does not require an employer to return someone to that work. Nor does that initial test replace the later follow-up plan. This article addresses program administration, not a clinical assessment or a determination that any particular driver is eligible for an assignment.

A hiring handoff needs more than a Clearinghouse query result. FMCSA explains that the follow-up plan itself is not in the driver’s Clearinghouse record. Current section 382.413(b) specifically requires an employer to request an unfinished plan directly from the previous employer. Our proposed administrative check is to connect the received plan with the documented testing already completed and the remaining requirements before assuming the new carrier can carry it out. Ask the responsible program professionals to resolve missing or conflicting information. An employer change is not a reason to invent a fresh six-test schedule or declare the existing one finished.

Protect the plan’s unpredictability. Section 40.309 requires unannounced testing without a discernible timing pattern or advance notice. Section 40.307 also prohibits giving the employee the schedule or indicating its frequency or duration. Our suggested workflow is a restricted administrative record and a trained backup for the designated employer representative, rather than a shared dispatch calendar showing future tests. Coordinate collection logistics through the applicable DOT procedures without turning internal planning into advance notice. The carrier cannot continue safety-sensitive work unless follow-up testing is conducted as the SAP directs.

Close the file against evidence. Our recommended review asks which plan governs, which qualifying tests are completed, whether cancellations were resolved, and whether any remaining period includes an interruption in safety-sensitive duty. A provider’s invoice or a reassuring count of negative results cannot answer all four. Assign someone to resolve the discrepancies and confirm actual completion under the prescribed plan before recording it as finished. FMCSA separately requires the employer to report successful follow-up-plan completion to the Clearinghouse. That reporting step should reflect a verified program outcome, with the underlying plan and results handled through the carrier’s confidential testing-record procedures.